iocetamic acid
Trade name: cholebrine
Small moleculeapproved
Approved
May 16, 1973
Iocetamic acid is a medical diagnostic aid. It is a contrast agent used to enhance structures or fluids during X-ray imaging. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1970s
- May 16, 1973
Mallinckrodt — Earliest FDA Approval
- May 16, 1973
Mallinckrodt — NDA Secondary Org
- May 16, 1973
Mallinckrodt — NDA Organization
Indications
Approved for
Mechanism of action
- contrast mediumRadiopaque
contrast medium radiopaque
Approval history
- approvedMay 16, 1973
Chemistry & pharmacology
Loading structure…
SMILES
CC(CN(C(C)=O)C1=C(I)C=C(I)C(N)=C1I)C(O)=O- Mol. weight
- 613.9566 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
- Delivery
- Oral
- Availability
- Discontinued
Oral
Yes
Parenteral
No
Topical
No
Sources
- WikipediaIocetamic acid ↗
- NCATSFA675Q0E3E ↗
- ChEMBLCHEMBL1200770 ↗
Also known as
- cholebrine
- cholebrine
- cholebrine
- cholebrine
- iocetamic acid
- iocetamic acid
- iocetamic acid
- iocetamic acid
- iocetamic acid
- iocetamic acid
- iocetamic acid
- mp-620
- mp-620
- n-acetyl-n-(3-amino-2,4,6-triiodophenyl)-2-methyl-beta-alanine
Organizations
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Mallinckrodt | For profit | NDA2 | May 16, 1973 |
| Mallinckrodt | For profit | NDA | May 16, 1973 |